Literature DB >> 33672887

Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients.

Bei Gao1,2, Xinlian Zhang3, Bernd Schnabl2,4.   

Abstract

Alcohol-related liver disease is one of the most prevalent types of chronic liver diseases globally. Alcohol-related liver disease begins with fatty liver, which further develops into hepatic inflammation, hepatocyte injury, and progresses to fibrosis and cirrhosis. Compositional changes of gut bacteria and fungi were found in patients with alcohol-related liver disease. However, the functional changes of fungi and correlations between fungi and bacteria have not been investigated. In this study, we first examined the functional capacity of fungi in patients with alcohol-related liver disease using shotgun metagenomics. Among 24 MetaCyc pathways contributed by fungi, superpathway of allantoin degradation in yeast was enriched in patients with alcoholic hepatitis. Furthermore, we compared the predictive power of bacteria versus fungi and found that bacteria performed better than fungi to separate patients with alcoholic hepatitis from non-alcoholic controls and patients with alcohol use disorder. Finally, we investigated the associations between the intestinal fungi and bacteria in alcoholic hepatitis patients. Positive association between fungi and bacteria was found between Cladosporium and Gemmiger, meanwhile negative association was found between Cryptococcus and Pseudomonas in alcoholic hepatitis patients.

Entities:  

Keywords:  ITS sequencing; alcoholic hepatitis; mycobiota

Mesh:

Year:  2021        PMID: 33672887      PMCID: PMC7917833          DOI: 10.3390/toxins13020143

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   5.075


  22 in total

1.  Pseudomonas aeruginosa inhibits the growth of Cryptococcus species.

Authors:  Antonella Rella; Mo Wei Yang; Jordon Gruber; Maria Teresa Montagna; Chiara Luberto; Yong-Mei Zhang; Maurizio Del Poeta
Journal:  Mycopathologia       Date:  2011-11-11       Impact factor: 2.574

Review 2.  [Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation].

Authors:  Anis Ben Haj Khalifa; Didier Moissenet; Hoang Vu Thien; Mohamed Khedher
Journal:  Ann Biol Clin (Paris)       Date:  2011 Jul-Aug       Impact factor: 0.459

3.  Sparse and compositionally robust inference of microbial ecological networks.

Authors:  Zachary D Kurtz; Christian L Müller; Emily R Miraldi; Dan R Littman; Martin J Blaser; Richard A Bonneau
Journal:  PLoS Comput Biol       Date:  2015-05-07       Impact factor: 4.475

4.  Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis.

Authors:  Iliyan D Iliev; Vincent A Funari; Kent D Taylor; Quoclinh Nguyen; Christopher N Reyes; Samuel P Strom; Jordan Brown; Courtney A Becker; Phillip R Fleshner; Marla Dubinsky; Jerome I Rotter; Hanlin L Wang; Dermot P B McGovern; Gordon D Brown; David M Underhill
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

5.  Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.

Authors:  Min Wang; Wei-Yang Chen; Jingwen Zhang; Leila Gobejishvili; Shirish S Barve; Craig J McClain; Swati Joshi-Barve
Journal:  Hepatology       Date:  2020-10-15       Impact factor: 17.425

6.  Intestinal fungi contribute to development of alcoholic liver disease.

Authors:  An-Ming Yang; Tatsuo Inamine; Katrin Hochrath; Peng Chen; Lirui Wang; Cristina Llorente; Sena Bluemel; Phillipp Hartmann; Jun Xu; Yukinori Koyama; Tatiana Kisseleva; Manolito G Torralba; Kelvin Moncera; Karen Beeri; Chien-Sheng Chen; Kim Freese; Claus Hellerbrand; Serene Ml Lee; Hal M Hoffman; Wajahat Z Mehal; Guadalupe Garcia-Tsao; Ece A Mutlu; Ali Keshavarzian; Gordon D Brown; Samuel B Ho; Ramon Bataller; Peter Stärkel; Derrick E Fouts; Bernd Schnabl
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 19.456

7.  Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.

Authors:  Sonja Lang; Bradley Fairfied; Bei Gao; Yi Duan; Xinlian Zhang; Derrick E Fouts; Bernd Schnabl
Journal:  Gut Microbes       Date:  2020-07-20

Review 8.  Alcoholic Liver Disease: Pathogenesis and Current Management.

Authors:  Natalia A Osna; Terrence M Donohue; Kusum K Kharbanda
Journal:  Alcohol Res       Date:  2017

Review 9.  Introduction to the human gut microbiota.

Authors:  Elizabeth Thursby; Nathalie Juge
Journal:  Biochem J       Date:  2017-05-16       Impact factor: 3.857

10.  Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.

Authors:  Amandine Everard; Sébastien Matamoros; Lucie Geurts; Nathalie M Delzenne; Patrice D Cani
Journal:  mBio       Date:  2014-06-10       Impact factor: 7.867

View more
  3 in total

Review 1.  Roles for the mycobiome in liver disease.

Authors:  Suling Zeng; Bernd Schnabl
Journal:  Liver Int       Date:  2022-01-17       Impact factor: 5.828

Review 2.  Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.

Authors:  Bernd Schnabl; Gavin E Arteel; Felix Stickel; Jan Hengstler; Nachiket Vartak; Ahmed Ghallab; Steven Dooley; Yujia Li; Robert F Schwabe
Journal:  Z Gastroenterol       Date:  2022-01-18       Impact factor: 1.769

Review 3.  Gut non-bacterial microbiota contributing to alcohol-associated liver disease.

Authors:  Wenkang Gao; Yixin Zhu; Jin Ye; Huikuan Chu
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.